Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500364 · ClinicalTrials.gov registry record · Phase 4
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
A Phase 4 study of Femoroacetabular Impingement, sponsored by American Hip Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06500364: Recruiting Phase 4 study of Femoroacetabular Impingement, sponsored by American Hip Institute.
NCT06500364 is a Phase 4 study of Femoroacetabular Impingement that is actively recruiting participants, run by American Hip Institute. The registered enrollment target is 80 participants, below the 1,360-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06500364, a Phase 4 study of Femoroacetabular Impingement, is actively recruiting participants, sponsored by American Hip Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see if the Arthrex LoopLocTM device is better for capsular closure during hip arthroscopy than other treatments available. The hip capsule is the tissue that surrounds your hip joint. It stabilizes and supports your hip joint. During hip arthroscopy, this tissue must be cut through in order to perform the hip arthroscopy. Once the hip arthroscopy is completed, the surgeon might repair the capsule. Current ways of repairing the capsule include knotted suture that might irritate structures around the hip, leading to the possible formation of scar tissue and pain. The Arthrex LoopLocTM device is knotless and may lower the presence of irritation and scar tissue around the hip after surgery and might lead to better outcomes. Therefore, researchers will compare patients who had the LoopLocTM device used to close their hip capsule during surgery to those who did not have the device used, to see if there is a difference in their outcomes following surgery.
Primary Outcome
Patient-reported outcome measure. Scale 0-100, 100 indicating optimal function outcome.
Conditions Studied
Interventions
- DEVICE LoopLoc Arm
- DEVICE Control Arm
Study Locations (1)
Illinois
- American Hip Institute Research Foundation - Des Plaines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2027-08 |
| Phase | Phase 4 |
What NCT06500364 shows while recruiting
NCT06500364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,360-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Femoroacetabular Impingement appearing as the primary indexed condition, and to 2 interventions - of which LoopLoc Arm is the first listed.
NCT06500364 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06500364 about?
NCT06500364 is a clinical study titled "Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study". The purpose of this research is to see if the Arthrex LoopLocTM device is better for capsular closure during hip arthroscopy than other treatments available. The hip capsule is the tissue that surrounds your hip joint. It stabilizes and supports your hip joint. During hip arthroscopy, this tissue m...
What is the current status of trial NCT06500364?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2024-10-29. Estimated completion is 2027-08.
What conditions does trial NCT06500364 study?
This clinical trial studies the following conditions: Femoroacetabular Impingement.
What interventions are being tested in trial NCT06500364?
The interventions under investigation include: LoopLoc Arm (DEVICE), Control Arm (DEVICE).
Who is sponsoring clinical trial NCT06500364?
This trial is sponsored by American Hip Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06500364 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoroacetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06500364's enrollment target sits among peer trials
80 6th of 8 higher than 3 of 8 other Femoroacetabular Impingement trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Femoroacetabular Impingement trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
An Evaluation of Hip Preservation Outcomes
RECRUITING
-
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
RECRUITING · Phase 3
-
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
RECRUITING
-
SCP Hip Outcomes Study
ACTIVE NOT RECRUITING
-
Cam Decompression Utilizing the Stryker Hip-Check Software Platform
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI